About: Isomerization and formulation stability of the vaccine adjuvant QS-21

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Isomerization and formulation stability of the vaccine adjuvant QS-21 Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 January 1996

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в січні 1996 (uk) im Januar 1996 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xineru de 1996 (ast) artikull shkencor i botuar më 01 janar 1996 (sq) scientific article published on 01 January 1996 (en)
publication date	wds:Q71795020-1FEAD6F1-EFE6-42FB-86C1-2FC78533A8F0
publication date	1996-01-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q71795020-78FF2453-ED1D-4B07-A59B-E076727A87B9
language of work or name	English
cites work	wds:Q71795020-09DF29F8-F250-4700-92F5-0A44665FF051 wds:Q71795020-3453742A-3E09-44B9-9B3D-9B5D9D1BBA50 wds:Q71795020-8088998F-821E-42B2-B99B-7735F856C2B2 wds:Q71795020-C5477AD8-071F-407D-B268-F11BA9C8638D wds:Q71795020-E3C725EF-5DC0-4C65-9C3F-9A68CA8E225D wds:Q71795020-E40C44B2-2BD1-4623-A773-B476DD1A146E wds:Q71795020-E6266825-EEAD-4A1D-B937-CD54FFEFD402
cites work	Areas, volumes, packing and protein structure A fluorimetric method for the estimation of the critical micelle concentration of surfactants Characterization of the MN gp120 HIV-1 vaccine: antigen binding to alum. Phase 1 trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma Effect of adjuvants on immunogenicity of MN recombinant glycoprotein 120 in guinea pigs Immunogenicity and toxicity testing of an experimental HIV-1 vaccine in nonhuman primates Alkaline hydrolysis of phospholipids in model membranes and the dependence on their state of aggregation
author name string	wds:Q71795020-2B34950B-6B51-4524-AACC-87DF0331E856 wds:Q71795020-39C632E8-9DAF-48BC-9FC4-BE54FA5C2606 wds:Q71795020-59022C3A-B931-49A7-A6B2-37159479BF6A wds:Q71795020-77AF8313-C185-433D-9740-7402F95FDA0E wds:Q71795020-7B9714B1-1311-42FF-9CBC-72E847A0A4F1 wds:Q71795020-841B47D0-2246-4CFC-AC81-A6797B8E17A8 wds:Q71795020-892D26E2-6F8E-4B09-AA95-8AA4B67A6907 wds:Q71795020-BDA605DB-19B8-43F9-90BC-0FA6FB9F1A4C wds:Q71795020-E17FBE25-5EE6-4D41-90C2-B57AA9117F9A
author name string	Lim A Wu JY Wheeler DA Cleland JL Kensil CR Powell MF Spellman M Jacobsen NE Basa L
rdfs:label	Isomerization and formulation stability of the vaccine adjuvant QS-21 (en) Isomerization and formulation stability of the vaccine adjuvant QS-21 (nl) Isomerization and formulation stability of the vaccine adjuvant QS-21 (sq)
skos:prefLabel	Isomerization and formulation stability of the vaccine adjuvant QS-21 (en) Isomerization and formulation stability of the vaccine adjuvant QS-21 (nl) Isomerization and formulation stability of the vaccine adjuvant QS-21 (sq)
name	Isomerization and formulation stability of the vaccine adjuvant QS-21 (en) Isomerization and formulation stability of the vaccine adjuvant QS-21 (nl) Isomerization and formulation stability of the vaccine adjuvant QS-21 (sq)
title	wds:Q71795020-2D8840C8-0DB8-42AA-B92C-611324A70FDD
title	Isomerization and formulation stability of the vaccine adjuvant QS-21 (en)
page(s)	wds:Q71795020-31B2286A-9E38-4A19-B0A7-DD58DCD6878C
page(s)	22-28
instance of	wds:Q71795020-EB12E9F2-823D-4FE0-B1AD-505DCBCC3A8D
instance of	scholarly article
main subject	wds:Q71795020-68F786CD-DE3D-4CB3-B736-4103AA362AE6
main subject	immunologic adjuvant
PubMed ID	wds:Q71795020-9F7DACE5-66AB-4F31-B0EE-EF1D4559FAF6
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8926578
PubMed ID	8926578
published in	wds:Q71795020-2CCCDA4F-392B-443D-9998-AE4BE1571B40
published in	Journal of Pharmaceutical Sciences
issue	wds:Q71795020-841B070F-16D2-44A1-8A47-E2760BC257C1
volume	wds:Q71795020-4A24507D-4365-4B7B-97BB-0DA1DBAE0EB0
issue	1
volume	85
DOI	wds:Q71795020-6463581D-A881-4420-AFBB-AB289390144D
DOI	http://dx.doi.org/10.1021/JS9503136
DOI	10.1021/JS9503136
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q71795020
is cites work of	Novel acetylated triterpenoid saponins in a chromatographic fraction from Quillaja saponaria Molina Natural and synthetic saponin adjuvant QS-21 for vaccines against cancer Effective, nonsensitizing vaccination with culture filtrate proteins against virulent Mycobacterium bovis infections in mice. Characterization of the MN gp120 HIV-1 vaccine: antigen binding to alum. Development of semisynthetic triterpenoid saponin derivatives with immune stimulating activity Synthesis of QS-21-xylose: establishment of the immunopotentiating activity of synthetic QS-21 adjuvant with a melanoma vaccine Synthetic studies of complex immunostimulants from Quillaja saponaria: synthesis of the potent clinical immunoadjuvant QS-21Aapi. Haemolytic activities and adjuvant effect of Astragalus membranaceus saponins (AMS) on the immune responses to ovalbumin in mice. Development of a single-shot subunit vaccine for HIV-1. 5. programmable in vivo autoboost and long lasting neutralizing response New advances in microsphere-based single-dose vaccines Altered immunomodulating and toxicological properties of degraded Quillaja saponaria Molina saponins. Relationship between haemolytic and adjuvant activity and structure of protopanaxadiol-type saponins from the roots of Panax notoginseng Degradation of Quillaja saponaria Molina saponins: loss of the protective effects of a herpes simplex virus 1 subunit vaccine Design and synthesis of potent Quillaja saponin vaccine adjuvants Preclinical evaluation of the synthetic adjuvant SQS-21 and its constituent isomeric saponins Prevention of rotavirus infections in vitro with aqueous extracts of Quillaja Saponaria Molina Characterization of in vivo anti-rotavirus activities of saponin extracts from Quillaja saponaria Molina Adjuvant effect of water-soluble polysaccharide (PAP) from the mycelium of Polyporus albicans on the immune responses to ovalbumin in mice Acylated and deacylated saponins of Quillaja saponaria mixture as adjuvants for the FML-vaccine against visceral leishmaniasis Development of Improved Vaccine Adjuvants Based on the Saponin Natural Product QS-21 through Chemical Synthesis Quillaja Saponin Variants with Central Glycosidic Linkage Modifications Exhibit Distinct Conformations and Adjuvant Activities Enhancing Immunogenicity of Cancer Vaccines: QS-21 as an Immune Adjuvant Design, synthesis, and immunologic evaluation of vaccine adjuvant conjugates based on QS-21 and tucaresol Versatile strategy for the divergent synthesis of linear oligosaccharide domain variants of Quillaja saponin vaccine adjuvants. Atomic model and micelle dynamics of QS-21 saponin Immunological adjuvant effect of Japanese ginseng saponins (JGS) on specific antibody and cellular response to ovalbumin and its haemolytic activities. Synthesis and Evaluation of QS-7-Based Vaccine Adjuvants

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software